The Continuing Resolution provides flat funding for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA) through December 11, 2020, and does not include any emergency or additional funding for the NIH to mitigate disruptions to trials/research due to COVID-19.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
The Association for Clinical Oncology (ASCO) held its first-ever virtual Advocacy Summit and online Week of Action September 9 – 18, 2020. The largest Advocacy Summit to date, 170 ASCO volunteer leaders and oncology care providers participated in 200 virtual meetings with Members of Congress and their staff to advocate for policies that would improve access to high-quality, equitable care for people with cancer and ensure robust funding for cancer research. Participants represented 44 different states, as well as Puerto Rico and the District of Columbia.
The Association for Clinical Oncology (ASCO) today presented Representative Rosa DeLauro (CT-3) with the annual Congressional Champion for Cancer Care Award in recognition of her exceptional commitment to bipartisan support for cancer research and treatment. The award honors a Member of Congress who is a leading champion for patients and survivors of cancer, their families, and their cancer care teams.
On September 16, the Association for Clinical Oncology (ASCO) will be hosting its first ever completely virtual Advocacy Summit. Oncology care providers from across the United States will meet with Members of Congress and their staff by phone or video to advocate for policies that will improve access to high-quality, equitable care for people with cancer and ensure robust funding for cancer research.
In testimony submitted to Congress about the federal budget for FY 2021, ASCO thanked lawmakers for increasing funding for cancer research in FY2020 and urged them to increase funding for the National Institutes of Health (NIH), the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the Centers for Disease Control and Protection (CDC) in the year ahead.
On March 6, 2020, President Trump signed into law the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020. This $8.3 billion package provides funding for the country’s response to coronavirus, including amongst its many provisions an emergency telehealth waiver, vaccine development, support for state and local governments, and assistance for affected small businesses.
Highlights from the bill include:
Emergency Telehealth Waiver ($500 million estimated cost)
The Association for Clinical Oncology (ASCO) is calling on Members of Congress to continue their support for federally funded research by providing $44.7 billion for the National Institutes of Health (NIH), including $6.9 billion for the National Cancer Institute (NCI) in Fiscal Year (FY) 2021. The $3 billion funding increase for NIH will help the agency continue to regain some of the ground it lost after years of effectively flat budgets so the U.S. biomedical research enterprise can continue its important work in support of new advances and cures for patients.
The meetings focused on drug pricing, access to clinical trials, Medicaid expansion and block grants, accelerated drug approval pathways, and other issues affecting people with cancer and their oncology care teams.
The American Society of Clinical Oncology (ASCO) released a position statement, “Block Grants in Medicaid & Their Impact on Cancer Care,” summarizing the Society’s concerns about the potential negative impact that recent proposals to establish annual limits on federal funding for Medicaid—or block grants—could have on patients with cancer. The statement urges state and federal policymakers not to enact, apply for, or advance any proposals to establish block grants for Medicaid programs.
President Trump recently signed into law a bill that funds the federal government for Fiscal Year (FY) 2020 and raises the purchasing age of tobacco products to 21.